Logo

American Heart Association

  16
  0


Final ID: MP2320

PREVENT Heart Failure Equations Underpredict Physician-Adjudicated Heart Failure Events Among People with HIV in the Multi-Center CNICS Cohort

Abstract Body (Do not enter title and authors here): Background: HIV infection is associated with increased risk of heart failure (HF). The American Heart Association recently developed the Predicting Risk of Cardiovascular Events (PREVENT) equations, which includes a calculator for 10-year risk of HF events. This calculator has not yet been validated among people with HIV (PWH) at risk for HF.

Purpose: The purpose of this study was to evaluate the PREVENT 10-year HF risk prediction calibration and discrimination among a diverse, multicenter cohort study of PWH with physician-adjudicated heart failure events.

Hypothesis: The PREVENT 10-year HF equations will have acceptable discrimination and strong calibration.

Methods: We included adults ages 30-79 years old with HIV and without HF enrolled in the Center for AIDS Research Network of Integrated Clinical Systems (CNICS) Cohort at two sites (University of Washington and University of Alabama at Birmingham) that participated in physician adjudication of HF events from 2008 to 2021. We calculated predicted 10-year HF risk at baseline using the PREVENT 10-year base equation. HF events were adjudicated according to a standard protocol by two cardiologists independently, with discrepancies resolved by a third reviewer. Follow-up was until first HF event, death, loss to follow-up, or end of the study period. We used Harrell’s C-index to assess discrimination and the Kaplan-Meier approximation of the Greenwood-Nam-D’Agostino estimator (to account for variable follow-up time) and goodness-of-fit test to assess calibration.

Results: We included 4,970 individuals with a mean age of 44 and 20% female (Table). The mean predicted 10-year risk of HF by PREVENT was 2.5% (SD: 4.9) [median=1.1% (IQR: 0.5-2.5)]. Over a median of 6.1 years of follow-up (IQR: 2.4-9.4), 125 individuals had an incident HF event. Discrimination by Harrell’s C-index was 0.760 (95% CI: 0.713-0.808). Using the Greenwood-Nam-D’Agostino estimator, the ratio of observed events to predicted events by the PREVENT HF equation over ten years was 1.47 (p<0.001). The calibration slope by decile of predicted risk was 1.035 for PREVENT (Figure).

Conclusions: Among a cohort of people with HIV in the United States, the PREVENT 10-year HF equation has acceptable discrimination but is poorly calibrated, with the observed probability of events ~50% higher than the predicted risk across deciles of predicted risk.
  • Durstenfeld, Matthew  ( UCSF , San Francisco , California , United States )
  • Delaney, Joseph  ( University of Washington , Seattle , Washington , United States )
  • Crane, Heidi  ( University of Washington , Seattle , Washington , United States )
  • Feinstein, Matthew  ( NORTHWESTERN UNIV - FEINBERG SCHOOL , Chicago , Illinois , United States )
  • Kyle, Ryan  ( University of Washington , Seattle , Washington , United States )
  • Whitney, Bridget  ( University of Washington , Seattle , Washington , United States )
  • Hoffmann, Alexander  ( University of Washington , Seattle , Washington , United States )
  • Cichowitz, Cody  ( UCSF , San Francisco , California , United States )
  • Hunt, Peter  ( UCSF , San Francisco , California , United States )
  • Longenecker, Chris  ( University of Washington , Seattle , Washington , United States )
  • Hsue, Priscilla  ( University of California Los Angeles , Los Angeles , California , United States )
  • Burkholder, Greer  ( University of Alabama at Birmingham , Birmingham , Alabama , United States )
  • Author Disclosures:
    Matthew Durstenfeld: DO have relevant financial relationships ; Consultant:Merck:Past (completed) | Joseph Delaney: DO NOT have relevant financial relationships | Heidi Crane: No Answer | Matthew Feinstein: DO have relevant financial relationships ; Advisor:Novo Nordisk:Past (completed) ; Advisor:Gilead:Past (completed) ; Advisor:Abbott:Past (completed) | Ryan Kyle: No Answer | Bridget Whitney: DO NOT have relevant financial relationships | Alexander Hoffmann: DO NOT have relevant financial relationships | Cody Cichowitz: DO NOT have relevant financial relationships | Peter Hunt: DO have relevant financial relationships ; Research Funding (PI or named investigator):Gilead:Active (exists now) ; Other (please indicate in the box next to the company name):Merck (drug donation for NIH-sponsored trial):Past (completed) ; Speaker:Viiv:Past (completed) ; Speaker:Gilead:Past (completed) ; Consultant:Viiv:Past (completed) ; Consultant:Merck:Past (completed) | Chris Longenecker: DO have relevant financial relationships ; Advisor:Gilead Sciences:Past (completed) | Priscilla Hsue: DO have relevant financial relationships ; Consultant:Gilead:Past (completed) ; Advisor:Marea Therapeutics:Active (exists now) ; Research Funding (PI or named investigator):Abbott:Past (completed) ; Consultant:Genentech:Active (exists now) | Greer Burkholder: No Answer
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Advances in Predicting Heart Failure and Cardiomyopathy: From Risk Stratification to Early Detection

Monday, 11/10/2025 , 09:15AM - 10:30AM

Moderated Digital Poster Session

More abstracts on this topic:
Administration of Nicotinamide Mononucleotide Mitigates the HIV Nef-induced Metabolic and Pathological Changes in the Heart

Nakhungu Esther, Kondrachuk Olena, Ogundipe Gbenga, Kimura Yuka, Rappaport Jay, Gupta Manish

A Cardiac Targeting Peptide Linked to miRNA106a Targets and Suppresses Genes Known to Cause Heart Failure: Reversing Heart Failure at the Source

Lu Ming, Deng Claire, Taskintuna Kaan, Ahern Gerard, Yurko Ray, Islam Kazi, Zahid Maliha, Gallicano Ian

More abstracts from these authors:
Acceptability of Cardiovascular Prevention Strategies Among People With HIV: a Mixed-Methods Study

Durstenfeld Matthew, Levkova Marta, Schaffer Veronica, De Leon Ivan, Dejong Colette, Sauceda John, Gandhi Monica, Hsue Priscilla

Risk Scores Only Weakly Predict Volume of Non-Calcified Coronary Plaque among People with HIV

Durstenfeld Matthew, Levkova Marta, Jung Matthias, Karady Julia, Li Danny, Schaffer Veronica, Lu Michael, Hsue Priscilla

You have to be authorized to contact abstract author. Please, Login
Not Available